| 1 |
Bitar AN, Syed SulaimanSA, Ali I, et al. Osteoporosis among patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of prevalence, severity, and therapeutic outcomes[J]. J Pharm Bioallied Sci, 2019, 11(4): 310-320.
|
| 2 |
罗宸婧，盛芳芳，张静，等. 以全球视角对中国慢性阻塞性肺疾病负担及未来趋势分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(6): 855-860.
|
| 3 |
Kakoullis L, Sampsonas F, Karamouzos V, et al. The impact of osteoporosis and vertebral compression fractures on mortality and association with pulmonary function in COPD: A meta-analysis[J]. Joint Bone Spine, 2022, 89(1): 105249.
|
| 4 |
Li Y, Gao H, Zhao L, et al. Osteoporosis in COPD patients: Risk factors and pulmonary rehabilitation[J]. Clin Respir J, 2022, 16(7): 487-496.
|
| 5 |
Inoue D, Inoue R. Mechanisms of osteoporosis associated with chronic obstructive pulmonary disease[J]. J Bone Miner Metab, 2024, 42(4): 428-437.
|
| 6 |
Cecins E, Cavalheri V, Taaffe DR, et al. Prevalence of suspected poor bone health in people with chronic obstructive pulmonary disease-a cross-sectional exploratory study[J]. Chron Respir Dis, 2022, 19: 14799731221120429.
|
| 7 |
Deng AF, Wang FX, Wang SC, et al. Bone-organ axes: Bidirectional crosstalk[J]. Mil Med Res, 2024, 11(1): 37.
|
| 8 |
Ma C, Gao J, Liang J, et al. CCL12 induces trabecular bone loss by stimulating RANKL production in BMSCs during acute lung injury[J]. Exp Mol Med, 2023, 55(4): 818-830.
|
| 9 |
Nelson AJ, Roy SK, Warren K, et al. Sex differences impact the lung-bone inflammatory response to repetitive inhalant lipopolysaccharide exposures in mice[J]. J Immunotoxicol, 2018, 15(1): 73-81.
|
| 10 |
Inoue D, Inoue R. Mechanisms of osteoporosis associated with chronic obstructive pulmonary disease[J]. J Bone Miner Metab, 2024, 42(4): 428-437.
|
| 11 |
Xiong J, Tian J, Zhou L, et al. Interleukin-17A deficiency attenuated emphysema and bone loss in mice exposed to cigarette smoke[J]. Int J Chron Obstruct Pulmon Dis, 2020, 15: 301-310.
|
| 12 |
Hu X, Sun Y, Xu W, et al. Expression of RANKL by peripheral neutrophils and its association with bone mineral density in COPD[J]. Respirology, 2017, 22(1): 126-132.
|
| 13 |
Suh YJ, McDonald MN, Washko GR, et al. Lung, Fat and bone: Increased adiponectin associates with the combination of smoking-related lung disease and osteoporosis[J]. Chronic Obstr Pulm Dis, 2018, 5(2): 134-143.
|
| 14 |
Munuswamy R, De BrandtJ, Burtin C, et al. Monomeric CRP is elevated in patients with COPD compared to non-COPD control persons[J]. J Inflamm Res, 2021, 14: 4503-4507.
|
| 15 |
Sun X, Chen L, He Z. PI3K/Akt-Nrf2 and anti-inflammation effect of macrolides in chronic obstructive pulmonary disease[J]. Curr Drug Metab, 2019, 20(4): 301-304.
|
| 16 |
Peñailillo L, Miranda-Fuentes C, Gutiérrez S, et al. Systemic inflammation but not oxidative stress is associated with physical performance in moderate chronic obstructive pulmonary disease[J]. Adv Exp Med Biol, 2024, 1450: 121-130.
|
| 17 |
Shyam Prasad ShettyB, Chaya SK, Kumar VS, et al. Inflammatory biomarkers interleukin 1 beta (IL-1β) and tumour necrosis factor alpha (TNF-α) are differentially elevated in tobacco smoke associated COPD and biomass smoke associated COPD[J]. Toxics, 2021, 9(4): 72.
|
| 18 |
Lee Kuei-Chen, Wu Yung-Tsan, Chien Wu-Chien, et al. Osteoporosis and the risk of temporomandibular disorder in chronic obstructive pulmonary disease[J]. J Bone Miner Metab, 2021, 39(2): 201-211.
|
| 19 |
Zhang W, Cui Y, Sun L, et al. Correlation between serum inflammatory factors and psychosomatic syndrome in patients with chronic obstructive pulmonary disease: an observational study[J]. Front Psychiatry, 2025, 16: 1586399.
|
| 20 |
Ghotbi E, Hathaway QA, Hadidchi R, et al. Mild to moderate COPD, vitamin D deficiency, and longitudinal bone loss: the Multi-ethnic Study of Atherosclerosis[J]. Bone, 2025, 199: 117550.
|
| 21 |
Huang Z, Feng J, Feng X, et al. Loss of signal transducer and activator of transcription 3 impaired the osteogenesis of mesenchymal progenitor cells in vivo and in vitro[J]. Cell Biosci, 2021, 11(1): 172.
|
| 22 |
Otsuka Y, Kondo T, Aoki H, et al. IL-1β promotes osteoclastogenesis by increasing the expression of IGF2 and chemokines in non-osteoclastic cells[J]. J Pharmacol Sci, 2023, 151(1): 1-8.
|
| 23 |
Ying J, Wang P, Shi Z, et al. Inflammation-mediated aberrant glucose metabolism in subchondral bone induces osteoarthritis[J]. Stem Cells, 2023, 41(5): 482-492.
|
| 24 |
Yalcinsoy M, Beykumul A, Gulbas G, et al. Do disease stages affect oxidative stress in stable COPD？[J]. Heliyon, 2024, 10(10): e31188.
|
| 25 |
Shin S, Gombedza FC, Awuah BoadiE, et al. Reduction of TRPC1/ TRPC3 mediated Ca2＋ signaling protects oxidative stress-induced COPD[J]. Cell Signal, 2023, 107: 110681.
|
| 26 |
Mou K, Chan SMH, Vlahos R. Musculoskeletal crosstalk in chronic obstructive pulmonary disease and comorbidities: Emerging roles and therapeutic potentials[J]. Pharmacol Ther, 2024, 257: 108635.
|
| 27 |
Nabeshima T, Tsukamoto M, Wang KY, et al. Delayed cortical bone healing due to impaired nuclear Nrf2 translocation in COPD mice[J]. Bone, 2023, 173: 116804.
|
| 28 |
Ibrahim N′，Mohd NoorH′，Shuid AN, et al. Osteoprotective effects in postmenopausal osteoporosis rat model: Oral tocotrienol vs. intraosseous injection of tocotrienol-poly lactic-co-glycolic acid combination[J]. Front Pharmacol, 2021, 12: 706747.
|
| 29 |
Zhao F, Guo L, Wang X, et al. Correlation of oxidative stress-related biomarkers with postmenopausal osteoporosis: a systematic review and meta-analysis[J]. Arch Osteoporos, 2021, 16(1): 4.
|
| 30 |
Li Y, Gao H, Zhao L, et al. Osteoporosis in COPD patients: Risk factors and pulmonary rehabilitation[J]. Clin Respir J, 2022, 16(7): 487-496.
|
| 31 |
Ranjani R, Vinotha ATS. A prospective randomized controlled study：Theophylline on oxidative stress and steroid sensitivity in chronic obstructive pulmonary disease patients[J]. Int J Pharm Investig, 2017, 7(3): 119-124.
|
| 32 |
Sun M, Qian Y, Cai C, et al. The role and clinical significance of vitamin D in chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2025, 20: 2023-2033.
|
| 33 |
Chen X, Shen L, Gao C, et al. Vitamin D status and its associations with bone mineral density, bone turnover markers, and parathyroid hormone in Chinese postmenopausal women with osteopenia and osteoporosis[J]. Front Nutr, 2024, 10: 1307896
|
| 34 |
Minter M, van OdijkJ, Augustin H, et al. Vitamin D status and longitudinal changes in body composition in patients with chronic obstructive pulmonary disease-a prospective observational study[J]. Int J Chron Obstruct Pulmon Dis, 2024, 19: 1291-1302.
|
| 35 |
Zovko T, Galic K, Vasilj M, et al. Correlation of parathyroid hormone values with lung function parameters in patients with chronic obstructive pulmonary disease[J]. Cureus, 2024, 16(7): e64053.
|
| 36 |
Ruram AA, Chutia H, Bhattacharyya H, et al. Serum 25(OH) vitamin D deficiency among young adults in the East Khasi Hills district of Meghalaya and its influence on bone mineral density: Investigating the involvement of the RANKL/RANK/OPG system[J]. J Family Med Prim Care, 2024, 13(8): 3042-3048.
|
| 37 |
Özbudak P, Karata Ö，Kaçar C. Evaluation of 25(OH) vitamin D3 and quadriceps strength correlation in postmenopausal women: A cross-sectional study[J]. J Back Musculoskelet Rehabil, 2024, 37(3): 679-686.
|
| 38 |
Lei S, Zhang X, Song L, et al. Expert consensus on vitamin D in osteoporosis[J]. Ann Jt, 2025, 10: 1.
|
| 39 |
陈亚红，冯淬灵，王婧，等. 慢性阻塞性肺疾病免疫调节治疗专家共识[J]. 中国全科医学，2022, 25(24): 2947-2959.
|
| 40 |
杨丽青，高凌云，杨凌婧，等. 慢性阻塞性肺疾病急性加重住院病人一年内再住院危险因素分析[J]. 西南医科大学学报，2022, 45(5): 404-408.
|
| 41 |
Xia C, Xu H, Fang L, et al. β-catenin inhibition disrupts the homeostasis of osteogenic/adipogenic differentiation leading to the development of glucocorticoid-induced osteonecrosis of the femoral head[J]. Elife, 2024, 12: RP92469.
|
| 42 |
Wang T, Yang L, Liang Z, et al. Pulsed electromagnetic fields attenuate glucocorticoid-induced bone loss by targeting senescent LepR＋ bone marrow mesenchymal stromal cells[J]. Biomater Adv, 2022, 133: 112635.
|
| 43 |
Ahmad NB, Majed AAM, Syed ASS, et al. Assessment of osteoprotegerin and receptor activator of NF-κB ligand in malaysian male patients with chronic obstructive pulmonary disease: A cross-sectional study[J]. Rev Invest Clin, 2024, 76(6): 262-273.
|
| 44 |
Jamall IS, Ullery MC, Rocchietti MarchM, et al. Reversibility in male idiopathic osteoporosis possible[J]. Endocrinol Diabetes Metab Case Rep, 2023, 2023(2): 22-0407.
|
| 45 |
Wang X, Huang L, Jiang S, et al. Testosterone attenuates pulmonary epithelial inflammation in male rats of COPD model through preventing NRF1-derived NF-κB signaling[J]. J Mol Cell Biol, 2021, 13(2): 128-140.
|
| 46 |
Zhao Z, Du Y, Yan K, et al. Exercise and osteoimmunology in bone remodeling[J]. FASEB J, 2024, 38(7): e23554.
|
| 47 |
Liang B, Burley G, Lin S, et al. Osteoporosis pathogenesis and treatment: Existing and emerging avenues[J]. Cell Mol Biol Lett, 2022, 27(1): 72.
|
| 48 |
Ninomiya H, Fukuda S, Nishida-Fukuda H, et al. Osteoprotegerin secretion and its inhibition by RANKL in osteoblastic cells visualized using bioluminescence imaging[J]. Bone, 2025, 191: 117319.
|
| 49 |
Kim J, Seo D, Yoo SY, et al. Lung-homing nanoliposomes for early intervention in NETosis and inflammation during acute lung injury[J]. Nano Converg, 2025, 12(1): 8.
|
| 50 |
Yang B, Zhang G, Zhu Y, et al. Osteoblast-CD4＋ CTL Crosstalk Mediated by SIRT1/DAAM2 Axis prevents age-related bone loss[J]. Adv Sci (Weinh), 2025, 12(39): e01170.
|